While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...
Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...
Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...